Aims and Scope of Journal of Clinical Pharmacology
The Journal of Clinical Pharmacology is a peer-reviewed medical journal that covers the field of pharmacology. The editor-in-chief is Joseph S. Bertino, Jr. (Bertino Consulting). It was established in 1961 and is currently published by John Wiley & Sons in association with the American College of Clinical Pharmacology. Less
Key Metrics
CiteScore 

5
Impact Factor 

< 5
SJR 

Q2Pharmacology

SNIP 

0.98
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Clinical Pharmacology
Journal of Clinical Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1961 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Clinical Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Clinical Pharmacology
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of DISC-3405, a Novel Recombinant Humanized Monoclonal Antibody Targeting TMPRSS6, in Adult Healthy Volunteers.
- 1 May 2026
- Journal of clinical pharmacology
In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug-Metabolizing Enzymes.
- 1 May 2026
- Journal of clinical pharmacology
Evaluation of Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet of Islatravir and Lenacapavir.
- 1 May 2026
- Journal of clinical pharmacology
Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications.
- 1 May 2026
- Journal of clinical pharmacology
First-in-Human Dose Selection and Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Muscle-Specific Kinase Agonist Adimanebart (ARGX-119).
- 1 May 2026
- Journal of clinical pharmacology
170 Years of Mitochondrial Research and the Emergence of Mitochondrial Medicine.
- 1 May 2026
- Journal of clinical pharmacology
A Phase 1 Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study of DISC-3405, a Novel Recombinant Humanized Monoclonal Antibody Targeting TMPRSS6, in Adult Healthy Volunteers.
- 1 May 2026
- Journal of clinical pharmacology
In Vitro and Clinical Evaluation of Potential Interactions of Bemnifosbuvir with Drug-Metabolizing Enzymes.
- 1 May 2026
- Journal of clinical pharmacology
Evaluation of Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet of Islatravir and Lenacapavir.
- 1 May 2026
- Journal of clinical pharmacology
Physiologically Based Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Analysis for Ceftriaxone Dosing in Pregnant Women: Model Development and Clinical Applications.
- 1 May 2026
- Journal of clinical pharmacology
First-in-Human Dose Selection and Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Muscle-Specific Kinase Agonist Adimanebart (ARGX-119).
- 1 May 2026
- Journal of clinical pharmacology
170 Years of Mitochondrial Research and the Emergence of Mitochondrial Medicine.
- 1 May 2026
- Journal of clinical pharmacology